SCHEMBL10196353

SCHEMBL10196353

COC(=O)c1ccc(C(c2ccc(-c3ccc(-n4c(C)ccc4C)nn3)cc2)C(C)(C)C)nc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.37
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
KMT2A Q03164 1/20 0.34
OGA O60502 1/20 0.34
MAPT P10636 3/20 0.34
S1PR4 O95977 1/20 0.34
S1PR3 Q99500 1/20 0.34
KDM4E B2RXH2 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HPGDS O60760 1/20 0.32
GABRA5 P31644 3/20 0.32
TP53 P04637 2/20 0.31
RXFP1 Q9HBX9 1/20 0.31
POLB P06746 1/20 0.31
CRBN Q96SW2 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10196355 0.82 MAPK1 (0.37) MAPK1RAB9ANPC1KMT2AOGA
SCHEMBL13262103 0.81
SCHEMBL10197152 0.79 ALOX5AP (0.46) MAPK1RAB9ANPC1KMT2AOGA
SCHEMBL10196354 0.71 MKNK1 (0.51) MAPK1S1PR4S1PR3
SCHEMBL480272 0.66 PARP10 (0.49) KMT2AMAPTKDM4EALDH1A1POLB
SCHEMBL14642565 0.65 TRPV1 (0.50) RAB9ANPC1MAPTS1PR3KDM4E
SCHEMBL29598250 0.65 MAPK1 (0.61) MAPK1RAB9ANPC1MAPTKDM4E
SCHEMBL21033709 0.64 TDP1 (0.59) MAPK1RAB9ANPC1KMT2AMAPT
SCHEMBL29597652 0.64 MAPK1 (0.51) MAPK1RAB9ANPC1KMT2AMAPT
SCHEMBL13262241 0.63 KDM4E (0.38) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440672-B2 Diphenyl substituted alkanes MERCK SHARP & DOHME CORP. (US) 2013-05-14 US disclosed
US-8440672-B2 Diphenyl substituted alkanes MERCK SHARP & DOHME CORP. (US) 2013-05-14 US disclosed
EP-2064204-B1 INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP) MERCK SHARP & DOHME (US) 2012-02-01 EP disclosed
US-20100168076-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-01 US disclosed
WO-2008030369-A1 INHIBITORS OF 5 -LIPOXYGENASE ACTIVATING PROTEIN ( FLAP) MERCK & CO., INC. (US) 2008-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168076-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B MAPK1 1844/4885RAB9A 4348/4885NPC1 643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.